Ticker	Volume	Price	Price Delta
DJIA	15,405.90	+70.65	0.46%
S&P 500	1,670.83	+4.54	0.27%
Nasdaq	3,507.80	+11.37	0.33%

Ticker

Volume

Price

Price Delta

DJIA

15,405.90

+70.65

0.46%

S&P 500

1,670.83

+4.54

0.27%

Nasdaq

3,507.80

+11.37

0.33%

Ticker	Volume	Price	Price Delta
STOXX 50	2,821.65	-2.85	-0.10%
FTSE 100	6,803.87	+48.24	0.71%
DAX	8,472.20	+16.37	0.19%

Ticker

Volume

Price

Price Delta

STOXX 50

2,821.65

-2.85

-0.10%

FTSE 100

6,803.87

+48.24

0.71%

DAX

8,472.20

+16.37

0.19%

Ticker	Volume	Price	Price Delta
Nikkei	15,381.00	+20.21	0.13%
Hang Seng	23,366.40	-126.66	-0.54%
S&P/ASX 200	5,180.06	-28.98	-0.56%

Ticker

Volume

Price

Price Delta

Nikkei

15,381.00

+20.21

0.13%

Hang Seng

23,366.40

-126.66

-0.54%

S&P/ASX 200

5,180.06

-28.98

-0.56%

Exchange: Shanghai
Sector: Consumer, Cyclical
Industry: Retail
Sub-Industry: Retail-Drug Store

Shanghai No 1 Pharmacy Co Ltd

+ Add to Watchlist

600833:CH

8.420 CNY 0.350 4.34%

Share this quote:

Post this quote on one of these sites:

Copy permanent URL

As of 03:05:08 ET on 05/21/2013.

Snapshot for Shanghai No 1 Pharmacy Co Ltd (600833)

Open:	8.060	Day's Range:	8.030 - 8.430	Volume:	13,538,136
Previous Close:	8.070	52wk Range:	6.620 - 9.930	1-Yr Rtn:	+6.91%

Stock Chart for 600833

No chart data available.

600833:CH 8.420

8.070

Interactive 600833 Chart

…

Previous Close

Key Statistics for 600833

Current P/E Ratio (ttm)	51.4985
Estimated P/E(-)	-
Relative P/E vs. SHASHR	4.1596
Earnings Per Share (ttm)	0.1635
Est. EPS	-
Est. PEG Ratio	-
Market Cap (M CNY)	1,878.39
Shares Outstanding (M)	223.09
30 Day Average Volume	4,163,734
Price/Book (mrq)	3.8377
Price/Sale (ttm)	1.3646
Dividend Indicated Gross Yield	-%
Cash Dividend (CNY)	0.0500
Last Dividend	07/20/2012
5 Year Dividend Growth	-
Next Earnings Announcement	08/29/2013

mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 600833

Revenue
Net Income (M/CNY)

Profit Margin (%)

Company Profile & Key Executives for 600833

Shanghai NO. 1 Pharmacy Co., Ltd. trades and markets medical products on a retail basis, chain drug store basis, and a wholesale basis. The Company, through its subsidiaries, produces drugs, as well as develops, leases, and manages commercial real estate properties.